
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 649
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT00201994 | "SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia | ||
NCT03949894 | Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease | ||
NCT01210560 | Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD | ||
NCT01344876 | Phase I Study of OPB-51602 in Patients With Hematologic Malignancies | ||
NCT00657176 | An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors | ||
NCT02382276 | A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence | ||
NCT01447576 | Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder | ||
NCT01942148 | A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia | ||
NCT00508157 | A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome | ||
NCT02013622 | Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia | ||
NCT04049825 | A Phase 1 Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL | ||
NCT04038957 | A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging | ||
NCT01076322 | A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients | ||
NCT01631825 | A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients | ||
NCT00366925 | CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis | ||
NCT01895322 | Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis | ||
NCT04398225 | A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder | ||
NCT04786730 | A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder | ||
NCT01228682 | Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice | ||
NCT02174822 | A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects | ||
NCT00130039 | Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II | ||
NCT01111539 | Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD) | ||
NCT05363839 | To Assess the Safety, Tolerability and Pharmacokinetics of ACH-000029 in Healthy Subjects | ||
NCT00448357 | Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen | ||
NCT05504486 | Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety | ||
NCT04258839 | Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148 | ||
NCT00712686 | Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia | ||
NCT02085460 | A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer | ||
NCT01122927 | Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features. | ||
NCT01567527 | Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients | ||
NCT03018691 | Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis | ||
NCT05628103 | A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication | ||
NCT00948090 | PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients | ||
NCT00885079 | Confirmatory Study of OPC-12759 Ophthalmic Suspension | ||
NCT00283179 | Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia | ||
NCT06757764 | The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis | ||
NCT05542264 | A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia | ||
NCT03734302 | The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects | ||
NCT02054702 | Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia | ||
NCT02925221 | Canadian Medical Assessment of JINARC™ Outcomes Registry | ||
NCT05221502 | Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB | ||
NCT05971602 | Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis | ||
NCT01214421 | Tolvaptan Extension Study in Participants With ADPKD | ||
NCT01684202 | A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2) | ||
NCT00541502 | Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder | ||
NCT00791921 | Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA) | ||
NCT01451164 | A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia | ||
NCT01280721 | A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan] | ||
NCT02554721 | Pharmacodynamic Study of Cilostazol in Healthy Volunteers | ||
NCT01670279 | Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder |